These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 8918700

  • 1. Activation-induced peripheral blood T cell apoptosis is Fas independent in HIV-infected individuals.
    Katsikis PD, García-Ojeda ME, Wunderlich ES, Smith CA, Yagita H, Okumura K, Kayagaki N, Alderson M, Herzenberg LA, Herzenberg LA.
    Int Immunol; 1996 Aug; 8(8):1311-7. PubMed ID: 8918700
    [Abstract] [Full Text] [Related]

  • 2. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals.
    Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA, Herzenberg LA.
    J Exp Med; 1995 Jun 01; 181(6):2029-36. PubMed ID: 7539037
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection.
    Katsikis PD, Garcia-Ojeda ME, Torres-Roca JF, Tijoe IM, Smith CA, Herzenberg LA, Herzenberg LA.
    J Exp Med; 1997 Oct 20; 186(8):1365-72. PubMed ID: 9334376
    [Abstract] [Full Text] [Related]

  • 4. TNF receptor 2-deficient CD8 T cells are resistant to Fas/Fas ligand-induced cell death.
    Teh HS, Seebaran A, Teh SJ.
    J Immunol; 2000 Nov 01; 165(9):4814-21. PubMed ID: 11046004
    [Abstract] [Full Text] [Related]

  • 5. Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists.
    Estaquier J, Tanaka M, Suda T, Nagata S, Golstein P, Ameisen JC.
    Blood; 1996 Jun 15; 87(12):4959-66. PubMed ID: 8652808
    [Abstract] [Full Text] [Related]

  • 6. Beta-chemokines inhibit activation-induced death of lymphocytes from HIV-infected individuals.
    Pinto LA, Williams MS, Dolan MJ, Henkart PA, Shearer GM.
    Eur J Immunol; 2000 Jul 15; 30(7):2048-55. PubMed ID: 10940894
    [Abstract] [Full Text] [Related]

  • 7. Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection.
    Fraietta JA, Mueller YM, Yang G, Boesteanu AC, Gracias DT, Do DH, Hope JL, Kathuria N, McGettigan SE, Lewis MG, Giavedoni LD, Jacobson JM, Katsikis PD.
    PLoS Pathog; 2013 Jul 15; 9(10):e1003658. PubMed ID: 24130482
    [Abstract] [Full Text] [Related]

  • 8. Lack of control of T cell apoptosis under HAART. Influence of therapy regimen in vivo and in vitro.
    de Oliveira Pinto LM, Lecoeur H, Ledru E, Rapp C, Patey O, Gougeon ML.
    AIDS; 2002 Feb 15; 16(3):329-39. PubMed ID: 11834943
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway.
    Tateyama M, Oyaizu N, McCloskey TW, Than S, Pahwa S.
    Blood; 2000 Jul 01; 96(1):195-202. PubMed ID: 10891451
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. HIV type 1 Tat protein enhances activation-but not Fas (CD95)-induced peripheral blood T cell apoptosis in healthy individuals.
    Katsikis PD, García-Ojeda ME, Torres-Roca JF, Greenwald DR, Herzenberg LA, Herzenberg LA.
    Int Immunol; 1997 Jun 01; 9(6):835-41. PubMed ID: 9199966
    [Abstract] [Full Text] [Related]

  • 13. Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death.
    Wekerle T, Kurtz J, Sayegh M, Ito H, Wells A, Bensinger S, Shaffer J, Turka L, Sykes M.
    J Immunol; 2001 Feb 15; 166(4):2311-6. PubMed ID: 11160287
    [Abstract] [Full Text] [Related]

  • 14. Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children.
    Stricker K, Knipping E, Böhler T, Benner A, Krammer PH, Debatin KM.
    Cell Death Differ; 1998 Mar 15; 5(3):222-30. PubMed ID: 10200468
    [Abstract] [Full Text] [Related]

  • 15. Exposure of resting peripheral blood T cells to HIV-1 particles generates CD25+ killer cells in a small subset, leading to induction of apoptosis in bystander cells.
    Kameoka M, Suzuki S, Kimura T, Fujinaga K, Auwanit W, Luftig RB, Ikuta K.
    Int Immunol; 1997 Oct 15; 9(10):1453-62. PubMed ID: 9352350
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells.
    Mueller YM, Makar V, Bojczuk PM, Witek J, Katsikis PD.
    Int Immunol; 2003 Jan 15; 15(1):49-58. PubMed ID: 12502725
    [Abstract] [Full Text] [Related]

  • 18. The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells.
    Gehri R, Hahn S, Rothen M, Steuerwald M, Nuesch R, Erb P.
    AIDS; 1996 Jan 15; 10(1):9-16. PubMed ID: 8924258
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo.
    Sloand EM, Kumar PN, Kim S, Chaudhuri A, Weichold FF, Young NS.
    Blood; 1999 Aug 01; 94(3):1021-7. PubMed ID: 10419894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.